Brief: PepGen Inc Provides Update on Planned Initiation of Phase 1 Study of PGN-EDODM1 in Myotonic Dystrophy Type 1

PepGen

13/06/2023 21:50

June 13 (Reuters) - PepGen Inc  PEPG.O :
    * PEPGEN INC. PROVIDES UPDATE ON PLANNED INITIATION OF PHASE
1
STUDY OF PGN-EDODM1 IN MYOTONIC DYSTROPHY TYPE 1
    * PEPGEN INC-  WITHDRAWING PRIOR GUIDANCE ON TIMELINE FOR
INITIATING A PHASE 1 STUDY OF PGN-EDODM1 IN PATIENTS WITH
MYOTONIC DYSTROPHY TYPE 1 IN H1 2023
    * PEPGEN INC- WILL CONTINUE TO WORK CLOSELY WITH FDA TO LIFT
CLINICAL HOLD WHILST WE REMAIN FULLY COMMITTED TO INITIATING A
PHASE 1 STUDY OF PGN-EDODM1

Source text for Eikon:  ID:nGNXh51kN 
Further company coverage:  PEPG.O 

 ((Reuters.Briefs@thomsonreuters.com;))